Overview and Scope
Immunohematology is a branch of laboratory medicine that studies blood groups and the body’s immune response to foreign substances, particularly in blood transfusions. Immune hematological techniques are used to locate and address diagnostic issues in patients with hematological conditions, such as auto-immune hemolytic anemia.
Sizing and Forecast
The immunohematology market size has grown strongly in recent years. It will grow from $2.34 billion in 2023 to $2.49 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to advancements in blood transfusion science, prevalence of blood disorders, expansion of blood banks, government initiatives for blood safety, increased surgical procedures, awareness of transfusion-related risks.
The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.04 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, regulatory support for blood safety. Major trends in the forecast period include automation and high-throughput systems, molecular blood typing methods, antibody detection techniques, patient blood management programs, integration of ai in analysis, telemedicine integration..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Segmentation & Regional Insights
The immunohematology market covered in this report is segmented –
1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Emt), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
North America was the largest region in the immunohematology market in 2023. Asia-Pacific is expected to be the fastest growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp
Major Driver Impacting Market Growth
The rising prevalence rate of hematological disorders is expected to propel the growth of the immunohematology market going forward. Hematological disorders are a diverse group of conditions that affect the blood and the components of the blood, such as red blood cells, white blood cells, platelets, and plasma. Immunohematology is essential for safe and effective blood transfusions, as it helps to prevent transfusion reactions caused by incompatible blood types or the presence of antibodies in the recipient’s blood. Immunohematology techniques are also used to diagnose and treat diseases related to the immune system, which may impact the hematological system. For Instance, in 2020, according to Cancer Research UK, a UK-based research organization, the average number of new leukemia cases caused by hematological disorders in the UK is expected to climb from roughly 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Therefore, the rising prevalence rate of hematological disorders is driving the growth of the immunohematology market.
Key Industry Players
Major companies operating in the immunohematology market report are Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Harvard bioscience Inc., Cenogenics Corporation, Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Cellnovo Group, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.
The immunohematology market report table of contents includes:
1. Executive Summary
2. Immunohematology Market Characteristics
3. Immunohematology Market Trends And Strategies
4. Immunohematology Market – Macro Economic Scenario
5. Global Immunohematology Market Size and Growth
.
.
.
31. Global Immunohematology Market Competitive Benchmarking
32. Global Immunohematology Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Immunohematology Market
34. Immunohematology Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/gynecology-medical-lasers-global-market-report
https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report
https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
